Generics And Biosimilars Industry Reshaped By Transformations
Annual Top 50 Sees Leading Firms Change Position And New Entrants Join
The latest Generics Bulletin Top 50 ranking of global generics and biosimilars companies sees a new name in the top five amid transformations for some of the leading off-patent players. Meanwhile, a number of mid-level firms shift position and newcomers climb into the bottom of the table.
